European Psychiatry - Volume 33 - March 2016

362 / 812

S358 24th European Congress of Psychiatry / European Psychiatry 33S (2016) S349–S805
trait anxiety also predicted inattentive dimension, whereas trait
and state anxiety predicted hyperactive/impulsive dimension.
Conclusion Impulsivity is related with severity of ADHD symp-
toms and dimensions of ADHD although negative affect that is
related with dimensions may differ.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV27
The role of modified states of
consciousness in drug use
C. Freitas ∗, A.M. Mendes , S. Queirós
1 Centro Hospitalar do Tâmega e Sousa, Psiquiatria e Saude Mental,
Amarante, Portugal
2 Centro Respostas Integradas do Porto Central, ET Cedofeita, Porto,
Portugal
∗ Corresponding author.
Modified state of consciousness (MSC) is defined as a mental state
that can be subjectively recognized by an individual or by an objec-
tive observer of the individual, as representing a difference in the
psychological functioning of the “normal” state, alert and awake
of the individual. Drugs are products with definitions and concep-
tual boundaries, historically defined. The use of psychoactive drugs
is related to the increased plasticity of human subjectivity which
is reflected in various technical means to change the perception,
cognition, affect and mood. The authors propose to conduct a lit-
erature review on the types of MSC, the way to achieve them and
their implications in drug consumption pattern.
A MSC consists of dimensions such as self-oceanic limitlessness,
agonizing self-dissolution and visionary restructuring.
Normal MSC includes dreams, hypnagogic state and sleep. Others
may be induced by hypnosis, meditation or psychoactive sub-
stances. Those achieved by drugs allow the subject to access
feelings and sensations which go beyond the everyday reality or,
on the other hand, leakage of reality.
Anthropological studies show that in almost all civilizations, man
sought ways to induce MSC.
What characterizes the problematic or abusive use of certain sub-
stances is not necessarily the amount and frequency of drug use,
but the disharmony in the socio-cultural, family and psychosocial
contexts of the individual.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV28
Are there more mechanical restraint
in patients admitted for substance use
disorder?
L. Galindo ∗, M. Grifell , E.J. Peréz , F. Dinamarca ,
V. Chavarria , P. Salgado , V. Pérez
1 Barcelona, Spain
2 Instituto de Neuropsiquiatria y Adicciones – Parc de Salut Mar,
Psiquiatria, Barcelona, Spain
∗ Corresponding author.
Introduction and objectives Mechanical restraint is a therapeutic
procedure commonly applied in acute units in response to psy-
chomotor agitation. Its frequency is between 21 and 59% of patients
admitted. These patients represent a risk to both themselves and
for health workers. There is a myth that patients with substance
use disorder (SUD) are more aggressive and require more forceful
measures. There are not clinical studies that compared if there are
differences of the frequency of mechanical restrain in patients with
SUD.
The aim of this study is to explore the differences of frequency of
mechanical restraint on patients with SUD in the psychiatry acute
and dual pathology units and others psychiatric diagnostics.
Material and methods We reviewed retrospectively the infor-
matics record of all the mechanical restraints made and the total
discharges of the three acute care units and dual disorders of Neu-
ropsychiatry and Addictions Institute (INAD) of the Parc de Salut
Mar de Barcelona, between January 2012 and January 2015. For
every discharge the presence of at least one mechanical restraint
and theDSM-IVdiagnosticwere coded. Thenwas calculated the fre-
quency and proportion of mechanical retrains in every diagnostic
group.
Results The number of discharges analyzedwas 4659 fromwhich
838had an episode ofmechanical restraint. The 37%of patientswith
SUD of cocaine had an episode of mechanical restrain. The patients
with SUD of alcohol only the 4%, and there no one case on patients
with SUDof Cannabis. Thirty percent of patientswith schizophrenia
and 28% of bipolar disorder.
Acknowledgements L. Galindo is a Rio-Hortega-fellowship-(ISC-
III;CM14/00111).
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV29
Results of a smoking cessation
program in primary care
H. de la Red Gallego ∗, Y. González Silva , T. Montero Carretero ,
Á. Delgado de Paz , M.F. Sánchez A˜norga , E. Ca˜nibano Maroto ,
G. Isidro García , A. Álvarez Astorga , A. Alonso Sánchez ,
M. Martín Fernández , A. Álvarez Hodel , I. Pérez González ,
S. Nieto Sánchez , S. Calvo Sardón , I. González Gurdiel ,
R. Hernández Antón , S. Gómez Sánchez , C. Noval Canga ,
M.S. Hernández García , L. Rodríguez Andrés
1 Clinical Universitary Hospital, Psychiatry, Valladolid, Spain
2 Plaza del Ejército Health Center, Primary Care, Valladolid, Spain
3 Toreno Health Center, Primary Care, Toreno, Spain
4 Valladolid Oeste, Primary Care, Valladolid, Spain
5 Casa del Barco Health Center, Primary Care, Valladolid, Spain
6 Parquesol Health Center, Primary Care, Valladolid, Spain
7 Páramo del Sil Health Center, Primary Care, Páramo del Sil, Spain
∗ Corresponding author.
Introduction Smoking is an addictive and chronic disease.
Twenty-four percent of the Spanish population in 2012 smoked
daily.
Aims and objectives To evaluate a smoking cessation program in
a Primary Care Center.
Methods Observational, prospective study. We describe an indi-
vidualized smoking cessation in Plaza del Ejército Health Center
(Valladolid). Inclusion criteria: active smoker, ≥ 18 years old and
belonging to the Health Center. Exclusion: severe mental illness.
Included patients from November 2013 until January2014. Ended
in July 2014. Four Medical residents participated, we present the
results of one of them. During the first consultation motivational
interviewing was conducted, physical examination and treatment
was prescribed (cognitive behavioral therapy or drug treatment:
varenicline). In subsequent consultations interview and follow-up.
Variables: age, gender, pack-years, nicotine dependence (Fager-
strom) and Prochaska and DiClemente phase, weight, treatment
used, dropout rate and final withdrawal of snuff.
Results Eleven patients, mean age 48.18 (13.61), 7 (63.6) women.
Comorbidity: 6 (54.5) anxious-depressive pathology, 1 (9.1) dys-
thymia, 2 (18.2) endocrine pathology and 1 (9.1) respiratory
disease. Four (36.4) showed high dependency and 2 (18.2) extreme.
Media packages 20.50/year (19,20). Seven (63.6) were in action
phase of Prochaska and DiClemente and 2 (18.2) in preparation.
Visits range: 1-11. The average was 4.55 (3.64). Three (27.27)